Frontage

Frontage Laboratories is a full-service, revenue-generating contract research organization (CRO) and contract development and manufacturing organization (CDMO) supporting the global biopharmaceutical industry. The company operates an integrated platform of drug discovery, development, and testing services, enabling clients to outsource critical R&D functions from hit identification through Phase II clinical trials. With a significant global footprint of 25 sites across North America, Asia-Pacific, and Europe, and approximately 1,800 employees, Frontage has established itself as a key player in the outsourced drug development sector. Its recent leadership promotions and strategic acquisitions indicate a focus on growth and service expansion.

Integrated pharmaceutical development service platform encompassing drug discovery (GDDS), preclinical DMPK/toxicology, bioanalytical testing, CMC/manufacturing (CDMO), and clinical/central lab services.

Frontage competes in a fragmented but competitive global market with large, full-service CROs like IQVIA, LabCorp, and Charles River Laboratories, as well as numerous specialized and regional CDMOs. Its differentiation lies in its integrated 'PDO' model offering services from discovery through Phase II and its strategic geographic presence in key markets.